David W. Bernard, M.D., Ph.D.
Clinical Pathology Residency, Hospital of the University of Pennsylvania, Philadelphia, PA
Dr. Bernard joined the Pathology Department at the Hospital of the University of Pennsylvania as an Instructor in 1995. After completing his clinical chemistry fellowship there, he assumed an Assistant Professorship appointment in the Departments of Pathology and Biochemistry at the MCP-Hahnemann School of Medicine of the Allegheny University of Health Sciences. From 1998 until 2004, Dr. Bernard was an Assistant Professor in the Department of Pathology at the Baylor College of Medicine in Houston, Texas. He left Baylor in 2004 to join the Methodist Hospital Physician Organization, and the Methodist Hospital Research Institute.
Dr. Bernard’s current research focuses on improved utilization and effectiveness of clinical testing and information technology for identification and treatment of hospitalized patients. Additionally, Dr. Bernard is Director of the Pathology Core Laboratories for TMHRI including the Serum and Tissue Banks. Also, the effect of clinical information technology on medical error reduction and improvement of patient safety are active interests.
Information technology, clinical decision support, medical errors
Wang P, Molina CP, Maldonado JE, Bernard DW. In utero drugs of abuse exposure testing for newborn twins. J Clin Pathol. 2010 Mar;63(3):259-61. PMID: 20203227
Olsen RJ, Tang Z, Farkas DH, Bernard DW, Zu Y, Chang CC. Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system. Arch Pathol Lab Med. 2006 Jul;130(7):997-1003. PMID: 16831057
Dasgupta A, Bernard DW. Herbal remedies: effects on clinical laboratory tests. Arch Pathol Lab Med. 2006 Apr;130(4):521-8. Review. PMID: 16594744
Johnson WJ, Jang SY, Bernard DW. Hormone sensitive lipase mRNA in both monocyte and macrophage forms of the human THP-1 cell line. Comp Biochem Physiol B Biochem Mol Biol. 2000 Aug;126(4):543-52. PMID: 11026666